Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (13,720,546)	$ (2,403,442)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	19,375	13,486
Options expense	29,738	79,163
Common stock issued for services	257,772	254,106
Bad debt expense		(246,683)
Loss on write-off of intangible asset		792,500
Loss on inventory investment		875,250
Goodwill impairment	5,129,115
Loss on inventory investments
Gain on sale of asset		(2,200)
Amortization of right-of-use assets	215,665	181,218
Amortization of intangible assets	814,790
Changes in operating assets and liabilities:
Accounts receivable, net	(293,784)	369,932
Prepaid assets and deposits	38,367	335,066
Inventory	4,232,947	(51,737)
Other receivables	(254,924)	(875,250)
Right-of-use assets	306,527
Lease liability	(534,997)	(164,618)
Accounts payable	1,607,625	199,833
Accrued liabilities	58,692	(211,694)
Purchase price payable	350,000
Current liabilities	2,794	67,517
Warrant liability	148,420	588,533
Net cash used in operating activities from continuing operations	(1,592,424)	(199,020)
Net cash used in operating activities from discontinued operations	(481,177)	(1,365,648)
Cash flows from investing activities:
Funds acquired through acquisitions	(344,454)
Proceeds from sale of fixed assets		749
Investment in capitalized software
Net cash (used in) investing activities from continuing operations	(344,454)	749
Net cash provided by investing activities from discontinued operations	68,737	(428,594)
Cash flows from financing activities:
Proceeds from the issuance of debt	400,000
Repayment of debt	(150,000)
Repayment of contingent liability	(1,043,107)	(716,964)
Proceeds from sale of future revenue	2,181,417	825,000
Proceeds from exercise of stock options
Proceeds from exercise of warrants	1,622	875
Proceeds from securities purchase agreement	516,400
Proceeds from issuance of common stock, net of issuance costs		130,918
Net cash provided by (used in) financing activities from continuing operations	1,906,332	239,829
Net cash (used in) financing activities from discontinued operations	(500,000)	(275,000)
Net decrease in cash	(942,986)	(2,027,684)
Cash at beginning of the year	1,094,894	3,122,578
Cash at end of the period	151,908	1,094,894
Supplemental disclosure of cash flow information
Cash paid for interest, net	733,694	336,206
Cash paid for income taxes
Non-Cash Transactions
Insurance premium financed	306,152	220,354
Note issued as SOSRx contribution		500,000
Not cancelled from SORx agreement termination	500,000
Intangible asset contribution from non-controlling interest		792,500
Disposition of assets, related party	492,030
Issuance of note receivable	$ 1,300,000